Discovery of LDK378, a potent and selective anaplastic lymphoma kinase (ALK) inhibitor for the treatment of ALK-driven cancers currently in Phase 1 and 2 clinical trials
Resource Type
Journal
Authors
Marsilje, Thomas H. ; Pei, Wei ; Chen, Bei ; Lu, Wenshuo ; Uno, Tetsuo ; Jin, Yunho ; Jiang, Tao ; Kim, Sungjoon ; Li, Nanxin ; Sarkisova, Yelena ; Sun, Fanxiang ; Steffy, Auzon ; Pferdekamper, Anne Marie C. ; Kasibhatla, Shailaja ; Joseph, Sean B. ; Kim, Young ; Tuntland, Tove ; Cui, Xiaoming ; Li, Jie ; Gordon, William ; Richmond, Wendy ; Chang, Jonathan ; Groessl, Todd ; He, You-Qun ; Liu, Bo ; Phimister, Andrew ; Bursulaya, Badry ; Lee, Christian ; Harris, Jennifer ; Michellys, Pierre-Yves
Source
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY ; APR 7 2013, 245 1p.
Subject
Language
English
ISSN
00657727